Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study
Ozdemir, Nesligul, Aktas, Burak Y., Gulmez, Ahmet, Inkaya, Ahmet C., Bayraktar-Ekincioglu, Aygin, Kilickap, Saadettin, Unal, Serhat
Published in Supportive care in cancer (01.03.2023)
Published in Supportive care in cancer (01.03.2023)
Get full text
Journal Article
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
Aktas, Burak Y, Taban, Hakan, Aksoy, Sercan, O’Sullivan, Hazel, Collins, Dearbhaile, O’Reilly, Seamus, Altundag, Kadri, Schmid, Peter, Chui, Stephen Y, Emens, Leisha A
Published in The New England journal of medicine (07.03.2019)
Published in The New England journal of medicine (07.03.2019)
Get full text
Journal Article
Vitamin D Supplementation and Prevention of Type 2 Diabetes
Aktaş, Burak Y, Öztürk Aktaş, Özge, Hassan-Smith, Zaki, Hewison, Martin, Gittoes, Neil, Mansur, Jose L, Pittas, Anastassios, Dawson-Hughes, Bess, Staten, Myrlene
Published in The New England journal of medicine (31.10.2019)
Published in The New England journal of medicine (31.10.2019)
Get full text
Journal Article
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors
Guven, Deniz C, Aktepe, Oktay H, Taban, Hakan, Aktas, Burak Y, Guner, Gurkan, Yildirim, Hasan C, Sahin, Taha K, Aksun, Melek S, Dizdar, Omer, Aksoy, Sercan, Erman, Mustafa, Yalcin, Suayib, Kilickap, Saadettin
Published in Biomarkers in medicine (01.09.2021)
Published in Biomarkers in medicine (01.09.2021)
Get full text
Journal Article
Dendrimer-enhanced (DEP) SN38 (DEP irinotecan) in patients (pts) with advanced solid tumors: A phase 1/2 trial
Liu, Jia (Jenny), Minchom, Anna Rachel, Greystoke, Alastair, Evans, T.R. Jeffry, Sarker, Debashis, Joshua, Anthony M., Morton, Cienne, Aktas, Burak Y, Cosman, Rasha, Chwialkowska, Dominika, Paull, Jeremy, Main, Nicola Jane, Jean-Francois, Bernadette Marie, Le Meur, Julia, Edmondson, Stephanie Ruth, Cook, Natalie
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
First-in-human phase I clinical trial of RSO-021, a first-in class covalent inhibitor of mitochondrial peroxiredoxin 3 (PRX3), in patients with malignant pleural effusion due to mesothelioma and other advanced solid tumors (MITOPE)
Fennell, Dean Anthony, Dulloo, Sean, Lord, Simon, Thistlethwaite, Fiona, Blyth, Kevin G, Szlosarek, Peter Wojciech, Maskell, Nick, Popat, Sanjay, Aujayeb, Avinash, Aktas, Burak Y, Javed, Sohail Rooman, Herrero Colomina, Julio, Cunniff, Brian, Duncan, Jarrett, Graham, Philippa, Bexon, Alice Susannah, Naumov, George N, Spicer, James F.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article